NO20051037L - Totalsyntese av myriaporoner - Google Patents

Totalsyntese av myriaporoner

Info

Publication number
NO20051037L
NO20051037L NO20051037A NO20051037A NO20051037L NO 20051037 L NO20051037 L NO 20051037L NO 20051037 A NO20051037 A NO 20051037A NO 20051037 A NO20051037 A NO 20051037A NO 20051037 L NO20051037 L NO 20051037L
Authority
NO
Norway
Prior art keywords
substituted
unsubstituted
group
aralkyl
aryl
Prior art date
Application number
NO20051037A
Other languages
English (en)
Norwegian (no)
Inventor
Andres Francesch
Carmen Cuevas Marchante
Marta Perez Lvarez
Carlos Del Pozo Losada
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Publication of NO20051037L publication Critical patent/NO20051037L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20051037A 2002-07-30 2005-02-25 Totalsyntese av myriaporoner NO20051037L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0217638.6A GB0217638D0 (en) 2002-07-30 2002-07-30 Total synthesis of myriaporones
PCT/GB2003/003327 WO2004011458A1 (en) 2002-07-30 2003-07-30 Total synthesis of myriaporones

Publications (1)

Publication Number Publication Date
NO20051037L true NO20051037L (no) 2005-04-13

Family

ID=9941374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051037A NO20051037L (no) 2002-07-30 2005-02-25 Totalsyntese av myriaporoner

Country Status (20)

Country Link
US (1) US7521478B2 (de)
EP (1) EP1532139B1 (de)
JP (1) JP2006504659A (de)
KR (1) KR20050053599A (de)
CN (1) CN100390167C (de)
AT (1) ATE364603T1 (de)
AU (1) AU2003248984A1 (de)
CA (1) CA2494532A1 (de)
DE (1) DE60314426T2 (de)
DK (1) DK1532139T3 (de)
ES (1) ES2289337T3 (de)
GB (1) GB0217638D0 (de)
IL (1) IL166484A0 (de)
MX (1) MXPA05001176A (de)
NO (1) NO20051037L (de)
NZ (1) NZ537678A (de)
PT (1) PT1532139E (de)
RU (1) RU2328492C2 (de)
SI (1) SI1532139T1 (de)
WO (1) WO2004011458A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514708A (en) * 1994-02-18 1996-05-07 Pharmamar, S.A. Cytotoxic metabolites from Myriapora truncata

Also Published As

Publication number Publication date
IL166484A0 (en) 2006-01-15
US20060084819A1 (en) 2006-04-20
CN1684956A (zh) 2005-10-19
KR20050053599A (ko) 2005-06-08
NZ537678A (en) 2006-11-30
CN100390167C (zh) 2008-05-28
GB0217638D0 (en) 2002-09-11
RU2005105329A (ru) 2005-08-27
DK1532139T3 (da) 2007-10-15
US20080103320A2 (en) 2008-05-01
RU2328492C2 (ru) 2008-07-10
US20080269511A2 (en) 2008-10-30
ATE364603T1 (de) 2007-07-15
PT1532139E (pt) 2007-09-20
JP2006504659A (ja) 2006-02-09
EP1532139A1 (de) 2005-05-25
CA2494532A1 (en) 2004-02-05
EP1532139B1 (de) 2007-06-13
DE60314426T2 (de) 2008-02-14
ES2289337T3 (es) 2008-02-01
DE60314426D1 (de) 2007-07-26
US7521478B2 (en) 2009-04-21
MXPA05001176A (es) 2005-09-12
SI1532139T1 (sl) 2007-10-31
WO2004011458A1 (en) 2004-02-05
AU2003248984A1 (en) 2004-02-16

Similar Documents

Publication Publication Date Title
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
NO20012617L (no) Kinolin- og kinzolinderivater
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
DK0535231T3 (da) Pyrimidinnucleosid-derivater
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
DE69617909T2 (de) 2-substituierte vitamin-d3-derivate
NO20051037L (no) Totalsyntese av myriaporoner
DE60237652D1 (de) Variolinderivate und ihre Verwendung als Cytostatika
NO20040189L (no) Nye antitumorderivater av ET-743
ATE552003T1 (de) Chinoxalinderivate
AU3387301A (en) Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application